Page last updated: 2024-08-20

2-chloroadenosine and Heart Failure

2-chloroadenosine has been researched along with Heart Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Liao, Y; Minamino, T; Ogai, A; Ogita, H; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H	1

Other Studies

1 other study(ies) available for 2-chloroadenosine and Heart Failure

Article	Year
Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circulation research, 2003, Oct-17, Volume: 93, Issue:8 Topics: 2-Chloroadenosine; Animals; Aorta; Cells, Cultured; Constriction; Cyclic AMP-Dependent Protein Kinases; Heart Failure; Heterotrimeric GTP-Binding Proteins; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Cell Surface; Ventricular Pressure	2003

Article

Year

Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.

Circulation research, 2003, Oct-17, Volume: 93, Issue:8

Topics: 2-Chloroadenosine; Animals; Aorta; Cells, Cultured; Constriction; Cyclic AMP-Dependent Protein Kinases; Heart Failure; Heterotrimeric GTP-Binding Proteins; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Cell Surface; Ventricular Pressure

2003